Parkside Financial Bank & Trust’s Guardant Health GH Stock Holding History

Parkside Financial Bank & Trust’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.1K	Buy	207 +123	+146%	+$12.3K	﹤0.01%	1321
2025 Q4	$8.58K	Hold	84	–	–	﹤0.01%	1632
2025 Q3	$5.25K	Sell	84 -546	-87%	-$29.7K	﹤0.01%	1721
2025 Q2	$32.8K	Sell	630 -161	-20%	-$7.19K	﹤0.01%	1043
2025 Q1	$33.7K	Buy	+791	New	+$34.1K	﹤0.01%	962
2023 Q3	–	Sell	-50	Closed	-$1.79K	–	2071
2023 Q2	$1.79K	Buy	50 +8	+19%	+$230	﹤0.01%	1721
2023 Q1	$985	Sell	42 -7	-14%	-$200	﹤0.01%	1850
2022 Q4	$1.33K	Sell	49 -13	-21%	-$595	﹤0.01%	1786
2022 Q3	$3K	Hold	62	–	–	﹤0.01%	1404
2022 Q2	$3K	Buy	62 +30	+94%	+$1.49K	﹤0.01%	1432
2022 Q1	$3K	Buy	32 +30	+1,500%	+$2.05K	﹤0.01%	1481
2021 Q4	$0	Sell	2 -11	-85%	-$1.14K	﹤0.01%	1838
2021 Q3	$2K	Sell	13 -7	-35%	-$832	﹤0.01%	1548
2021 Q2	$2K	Sell	20 -13	-39%	-$1.75K	﹤0.01%	1534
2021 Q1	$5K	Hold	33	–	–	﹤0.01%	1199
2020 Q4	$4K	Hold	33	–	–	﹤0.01%	1187
2020 Q3	$4K	Sell	33 -3	-8%	-$274	﹤0.01%	977
2020 Q2	$3K	Buy	+36	New	+$2.9K	﹤0.01%	1050

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkside Financial Bank & Trust's GH Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its Guardant Health (GH) stake by 146% in Q1 2026, buying an estimated $12.3K and bringing the position to 207 shares worth $19.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1321.

Parkside Financial Bank & Trust first reported a position in GH in Q2 2020 and has held it in 18 quarters since. The position peaked at $33.7K in Q1 2025. 482 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Parkside Financial Bank & Trust held 207 shares of Guardant Health worth $19.1K as of Q1 2026.
Parkside Financial Bank & Trust bought 123 Guardant Health shares in Q1 2026, an estimated $12.3K.
Guardant Health made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1321 holding.
Parkside Financial Bank & Trust first reported a position in Guardant Health in Q2 2020 and has held it in 18 quarters since.
Parkside Financial Bank & Trust's Guardant Health position peaked at $33.7K in Q1 2025.
482 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.